The global Viscosupplements market size was valued at USD 1874.8 million in 2023 and is forecast to a readjusted size of USD 2376.4 million by 2030 with a CAGR of 3.4% during review period.
Viscosupplementation is a medical procedure during which lubricating fluid is injected into a joint. Also called hyaluronic acid injections or hyaluronan injections, viscosupplementation is most commonly used to treat symptoms of symptoms of knee osteoarthritis.
A significant driver in the hyaluronic acid injections for joint pain market is the rising prevalence of osteoarthritis and the growing demand for non-surgical treatment options. Hyaluronic acid injections offer pain relief and improved joint function for individuals suffering from joint pain and osteoarthritis, making them a popular choice. However, a notable challenge in this market is the need for evidence-based research and reimbursement issues. Ensuring the effectiveness of hyaluronic acid injections through clinical studies and addressing reimbursement challenges can be barriers to broader market acceptance. Manufacturers and healthcare providers must collaborate to demonstrate the clinical benefits and cost-effectiveness of these injections to meet the demands of patients seeking non-surgical joint pain management solutions.
This report includes an overview of the development of the Viscosupplements industry chain, the market status of Hospital Pharmacies (Single Injection, Three Injection), Retail Pharmacies (Single Injection, Three Injection), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Viscosupplements.
Regionally, the report analyzes the Viscosupplements markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Viscosupplements market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Viscosupplements market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Viscosupplements industry.
The report involves analyzing the market at a macro level:
麻豆原创 Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Units), revenue generated, and market share of different by Type (e.g., Single Injection, Three Injection).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Viscosupplements market.
Regional Analysis: The report involves examining the Viscosupplements market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
麻豆原创 Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Viscosupplements market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Viscosupplements:
Company Analysis: Report covers individual Viscosupplements manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Viscosupplements This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital Pharmacies, Retail Pharmacies).
Technology Analysis: Report covers specific technologies relevant to Viscosupplements. It assesses the current state, advancements, and potential future developments in Viscosupplements areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Viscosupplements market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
麻豆原创 Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
麻豆原创 Segmentation
Viscosupplements market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
麻豆原创 segment by Type
Single Injection
Three Injection
Five Injection
麻豆原创 segment by Application
Hospital Pharmacies
Retail Pharmacies
Major players covered
Sanofi
Anika Therapeutics
Seikagaku
Zimmer Biomet
Bioventus
Ferring
LG Chem
Freda
Haohai Biological
Shanghai Jingfeng
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Viscosupplements product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Viscosupplements, with price, sales, revenue and global market share of Viscosupplements from 2019 to 2024.
Chapter 3, the Viscosupplements competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Viscosupplements breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Viscosupplements market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Viscosupplements.
Chapter 14 and 15, to describe Viscosupplements sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope of Viscosupplements
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Viscosupplements Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Single Injection
1.3.3 Three Injection
1.3.4 Five Injection
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Viscosupplements Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital Pharmacies
1.4.3 Retail Pharmacies
1.5 Global Viscosupplements 麻豆原创 Size & Forecast
1.5.1 Global Viscosupplements Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Viscosupplements Sales Quantity (2019-2030)
1.5.3 Global Viscosupplements Average Price (2019-2030)
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Viscosupplements Product and Services
2.1.4 Sanofi Viscosupplements Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 Sanofi Recent Developments/Updates
2.2 Anika Therapeutics
2.2.1 Anika Therapeutics Details
2.2.2 Anika Therapeutics Major Business
2.2.3 Anika Therapeutics Viscosupplements Product and Services
2.2.4 Anika Therapeutics Viscosupplements Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Anika Therapeutics Recent Developments/Updates
2.3 Seikagaku
2.3.1 Seikagaku Details
2.3.2 Seikagaku Major Business
2.3.3 Seikagaku Viscosupplements Product and Services
2.3.4 Seikagaku Viscosupplements Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 Seikagaku Recent Developments/Updates
2.4 Zimmer Biomet
2.4.1 Zimmer Biomet Details
2.4.2 Zimmer Biomet Major Business
2.4.3 Zimmer Biomet Viscosupplements Product and Services
2.4.4 Zimmer Biomet Viscosupplements Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Zimmer Biomet Recent Developments/Updates
2.5 Bioventus
2.5.1 Bioventus Details
2.5.2 Bioventus Major Business
2.5.3 Bioventus Viscosupplements Product and Services
2.5.4 Bioventus Viscosupplements Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Bioventus Recent Developments/Updates
2.6 Ferring
2.6.1 Ferring Details
2.6.2 Ferring Major Business
2.6.3 Ferring Viscosupplements Product and Services
2.6.4 Ferring Viscosupplements Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 Ferring Recent Developments/Updates
2.7 LG Chem
2.7.1 LG Chem Details
2.7.2 LG Chem Major Business
2.7.3 LG Chem Viscosupplements Product and Services
2.7.4 LG Chem Viscosupplements Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 LG Chem Recent Developments/Updates
2.8 Freda
2.8.1 Freda Details
2.8.2 Freda Major Business
2.8.3 Freda Viscosupplements Product and Services
2.8.4 Freda Viscosupplements Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 Freda Recent Developments/Updates
2.9 Haohai Biological
2.9.1 Haohai Biological Details
2.9.2 Haohai Biological Major Business
2.9.3 Haohai Biological Viscosupplements Product and Services
2.9.4 Haohai Biological Viscosupplements Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.9.5 Haohai Biological Recent Developments/Updates
2.10 Shanghai Jingfeng
2.10.1 Shanghai Jingfeng Details
2.10.2 Shanghai Jingfeng Major Business
2.10.3 Shanghai Jingfeng Viscosupplements Product and Services
2.10.4 Shanghai Jingfeng Viscosupplements Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.10.5 Shanghai Jingfeng Recent Developments/Updates
3 Competitive Environment: Viscosupplements by Manufacturer
3.1 Global Viscosupplements Sales Quantity by Manufacturer (2019-2024)
3.2 Global Viscosupplements Revenue by Manufacturer (2019-2024)
3.3 Global Viscosupplements Average Price by Manufacturer (2019-2024)
3.4 麻豆原创 Share Analysis (2023)
3.4.1 Producer Shipments of Viscosupplements by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2023
3.4.2 Top 3 Viscosupplements Manufacturer 麻豆原创 Share in 2023
3.4.2 Top 6 Viscosupplements Manufacturer 麻豆原创 Share in 2023
3.5 Viscosupplements 麻豆原创: Overall Company Footprint Analysis
3.5.1 Viscosupplements 麻豆原创: Region Footprint
3.5.2 Viscosupplements 麻豆原创: Company Product Type Footprint
3.5.3 Viscosupplements 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Viscosupplements 麻豆原创 Size by Region
4.1.1 Global Viscosupplements Sales Quantity by Region (2019-2030)
4.1.2 Global Viscosupplements Consumption Value by Region (2019-2030)
4.1.3 Global Viscosupplements Average Price by Region (2019-2030)
4.2 North America Viscosupplements Consumption Value (2019-2030)
4.3 Europe Viscosupplements Consumption Value (2019-2030)
4.4 Asia-Pacific Viscosupplements Consumption Value (2019-2030)
4.5 South America Viscosupplements Consumption Value (2019-2030)
4.6 Middle East and Africa Viscosupplements Consumption Value (2019-2030)
5 麻豆原创 Segment by Type
5.1 Global Viscosupplements Sales Quantity by Type (2019-2030)
5.2 Global Viscosupplements Consumption Value by Type (2019-2030)
5.3 Global Viscosupplements Average Price by Type (2019-2030)
6 麻豆原创 Segment by Application
6.1 Global Viscosupplements Sales Quantity by Application (2019-2030)
6.2 Global Viscosupplements Consumption Value by Application (2019-2030)
6.3 Global Viscosupplements Average Price by Application (2019-2030)
7 North America
7.1 North America Viscosupplements Sales Quantity by Type (2019-2030)
7.2 North America Viscosupplements Sales Quantity by Application (2019-2030)
7.3 North America Viscosupplements 麻豆原创 Size by Country
7.3.1 North America Viscosupplements Sales Quantity by Country (2019-2030)
7.3.2 North America Viscosupplements Consumption Value by Country (2019-2030)
7.3.3 United States 麻豆原创 Size and Forecast (2019-2030)
7.3.4 Canada 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Mexico 麻豆原创 Size and Forecast (2019-2030)
8 Europe
8.1 Europe Viscosupplements Sales Quantity by Type (2019-2030)
8.2 Europe Viscosupplements Sales Quantity by Application (2019-2030)
8.3 Europe Viscosupplements 麻豆原创 Size by Country
8.3.1 Europe Viscosupplements Sales Quantity by Country (2019-2030)
8.3.2 Europe Viscosupplements Consumption Value by Country (2019-2030)
8.3.3 Germany 麻豆原创 Size and Forecast (2019-2030)
8.3.4 France 麻豆原创 Size and Forecast (2019-2030)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Russia 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Italy 麻豆原创 Size and Forecast (2019-2030)
9 Asia-Pacific
9.1 Asia-Pacific Viscosupplements Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Viscosupplements Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Viscosupplements 麻豆原创 Size by Region
9.3.1 Asia-Pacific Viscosupplements Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Viscosupplements Consumption Value by Region (2019-2030)
9.3.3 China 麻豆原创 Size and Forecast (2019-2030)
9.3.4 Japan 麻豆原创 Size and Forecast (2019-2030)
9.3.5 Korea 麻豆原创 Size and Forecast (2019-2030)
9.3.6 India 麻豆原创 Size and Forecast (2019-2030)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2019-2030)
9.3.8 Australia 麻豆原创 Size and Forecast (2019-2030)
10 South America
10.1 South America Viscosupplements Sales Quantity by Type (2019-2030)
10.2 South America Viscosupplements Sales Quantity by Application (2019-2030)
10.3 South America Viscosupplements 麻豆原创 Size by Country
10.3.1 South America Viscosupplements Sales Quantity by Country (2019-2030)
10.3.2 South America Viscosupplements Consumption Value by Country (2019-2030)
10.3.3 Brazil 麻豆原创 Size and Forecast (2019-2030)
10.3.4 Argentina 麻豆原创 Size and Forecast (2019-2030)
11 Middle East & Africa
11.1 Middle East & Africa Viscosupplements Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Viscosupplements Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Viscosupplements 麻豆原创 Size by Country
11.3.1 Middle East & Africa Viscosupplements Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Viscosupplements Consumption Value by Country (2019-2030)
11.3.3 Turkey 麻豆原创 Size and Forecast (2019-2030)
11.3.4 Egypt 麻豆原创 Size and Forecast (2019-2030)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2019-2030)
11.3.6 South Africa 麻豆原创 Size and Forecast (2019-2030)
12 麻豆原创 Dynamics
12.1 Viscosupplements 麻豆原创 Drivers
12.2 Viscosupplements 麻豆原创 Restraints
12.3 Viscosupplements Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Viscosupplements and Key Manufacturers
13.2 Manufacturing Costs Percentage of Viscosupplements
13.3 Viscosupplements Production Process
13.4 Viscosupplements Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Viscosupplements Typical Distributors
14.3 Viscosupplements Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Sanofi
Anika Therapeutics
Seikagaku
Zimmer Biomet
Bioventus
Ferring
LG Chem
Freda
Haohai Biological
Shanghai Jingfeng
听
听
*If Applicable.
